Thermo Fisher Scientific

Stock Price



Market Capitalization

$222.7 B



$42.9 B

FY, 2023

Thermo Fisher Scientific Summary

Company Summary

Thermo Fisher Scientific is a biotechnology company engaged in service science. It operates in four business segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. Laboratory Products and Biopharma Services segment offers products and services for life science research and drug discovery and development. Life Sciences Solutions segment provides reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Analytical Instruments segment specializes in instruments, supporting consumables, software, and services for chromatography, mass spectrometry, chemical analysis, and electron microscopy. Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments, and associated products for clinical diagnostics, microbiology, and transplant diagnostics.
Waltham, MA, US | view all locations
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data

Key People

  • Marc N. Casper

    Marc N. Casper, Chairman, President and Chief Executive Officer

  • Alan Sachs

    Alan Sachs, Chief Medical Officer

  • Karen E. Nelson

    Karen E. Nelson, Chief Scientific Officer

  • Michel Lagarde

    Michel Lagarde, Executive Vice President & Chief Operating Officer

Operating MetricsView all

Remaining Performance Obligations


FY, 2023

LocationsView all

458 locations detected

  • Waltham, MA HQ

    United States

    168 3rd Ave

  • Agawam, MA

    United States

    325 Bowles Rd

  • Allentown, PA

    United States

    7554 Schantz Rd

  • Ann Arbor, MI

    United States

    110 Miller Ave

  • Asheville, NC

    United States

    275 Aiken Rd

  • Auburn, AL

    United States

    2039 McMillan St

and 452 others

Thermo Fisher Scientific Financials

Summary Financials

Revenue (FY, 2023)
Gross profit (FY, 2023)
Net income (FY, 2023)
Cash (FY, 2023)
EBIT (FY, 2023)
Enterprise value

Footer menu